Anew Medical, Inc. - WENA Balans kapitallashuvi

Anew Medical, Inc. (WENA) o'zining patentlangan miyani yoshartirish usullari asosida klinikalarning yopiq tarmog'ini tashkil etmoqda. Shu bilan birga, kompaniya suv iste'molini optimallashtirish uchun o'z laboratoriyalarida ekologik toza chiqindilarni utilizatsiya qilish standartlarini joriy qilmoqda. Ushbu ishlanmalarning yuqori ilmiy qiymati kompaniyani bozor dumpingidan himoya qiladi, asosiy ko'rsatkich esa -0.00 darajasida qolmoqda. Tahlil uchun mavjud narx harakati vektori quyida taqdim etilgan.

WENA Anew Medical Balans kapitallashuvi (25.06.2024 - 17.09.2024)

Anew Medical (WENA) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi anewmeds.com|WENA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Anew Medical Inc.|WENA - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Anew Medical|WENA - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti anewmeds.com|WENA - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Anew Medical, Inc.|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc.|WENA - Kompaniya qarzlari|Balans qiymatiga qarzlar Anew Medical Inc.|WENA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Anew Medical
Kompaniyaning jamlanma tahlili:WENA - anewmeds.com

Noyob gen terapiyasi usullarini ishlab chiquvchi Anew Medical, Inc. (WENA) uchun kompaniyaning umumiy balans kapitalizatsiyasi patent himoyasi ostidagi intellektual va moddiy bazasining barqarorligini aks ettiradi. Ushbu ko'rsatkich kapitalning kunlik qayta hisob-kitoblari orqali sof aktivlarning real qiymatini o'lchaydi, bunda indikatorning barqarorligi resurslarning saqlanganligini tasdiqlaydi, uning o'sishi esa aktivlar bazasining kengayishi va defolt risklarining minimallashtirilishidan dalolat beradi.

Anew Medical, Inc. raqobatchilari tahlili

BIIB - Buxgalteriya kapitallashuvi|NBIX: Balans kapitallashuvi|RGC (regencellbioscience.com) - Balans kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|TRVI (Trevi Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi PRAX|Kompaniyaning balans qiymati Anavex Life Sciences Corp. AVXL|Buxgalteriya kapitallashuvi CeriBell Inc (CBLL)|PRTA: Balans kapitallashuvi|ALEC - Kompaniyaning xususiy kapitali|ANNX: Kompaniyaning sof aktivlari|Omeros Corporation (OMER) - Kompaniyaning sof aktivlari|Kompaniyaning sof aktivlari Neurogene NGNE|ACIU (AC Immune S.A.) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati VYGR|Kompaniyaning sof aktivlari Neumora Corp|Scilex Holding Company - Balans kapitallashuvi|Kompaniyaning xususiy kapitali tevogen.com (TVGN)|ACOG - Balans kapitallashuvi|Buxgalteriya kapitallashuvi cogrx.com CGTX|Balans kapitallashuvi IKT (Inhibikase)|SAVA - Biznesning balans bahosi|ASRT (assertiotx.com) - Balans kapitallashuvi|Coya Therapeutics (COYA) - Kompaniyaning sof aktivlari|VTGN (VistaGen Therapeutics, Inc.) - Balans kapitallashuvi|Balans kapitallashuvi OVID|Kompaniyaning balans qiymati Acumen Pharma (ABOS)|Kompaniyaning balans qiymati CervoMed Corporation CRVO|Kompaniyaning sof aktivlari Alterity Therapeutics Limited|Kompaniyaning buxgalteriya qiymati Clene Inc CLNN|Balans kapitallashuvi PEPG (PepGen Corp)|JUNS: Biznesning balans bahosi|Kompaniyaning balans qiymati Relmada|Annovis Bio Corporation (ANVS) - Buxgalteriya kapitallashuvi|Balans kapitallashuvi GRCE|Kompaniyaning sof aktivlari fireflyneuro.com (AIFF)|KLTO (Klotho Neurosciences Inc) - Kompaniyaning sof aktivlari|Biznesning balans bahosi neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings - Kompaniyaning sof aktivlari|Kompaniyaning sof aktivlari MetaVia Inc. MTVA|NRXS (NeurAxis, Inc.) - Balans kapitallashuvi|HSDT: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati passagebio.com|Neuphoria Therapeutics (NEUP) - Buxgalteriya kapitallashuvi|NERV (Minerva Neurosciences Corp) - Balans kapitallashuvi|Balans kapitallashuvi ATHA|Kompaniyaning balans qiymati Addex Therapeutics ADXN|Buxgalteriya kapitallashuvi alzamend.com (ALZN)|CYCN: Balans kapitallashuvi|PTIX - Kompaniyaning xususiy kapitali|Pasithea - Kompaniyaning sof aktivlari|CRGT: Balans kapitallashuvi|Kompaniyaning balans qiymati Avenue Therapeutics ATXI|BCLI (brainstorm-cell.com) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati CARA (Cara Therapeutics)|Kompaniyaning xususiy kapitali Chromocell Therapeutics Corp|Balans kapitallashuvi ELYM|Balans kapitallashuvi ITCI (intracellulartherapies.com)|LBPH - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi marinuspharma.com MRNS|NKGN (NKGen Biotech) - Balans kapitallashuvi|NeuroBo Pharmaceuticals Inc (NRBO) - Kompaniyaning xususiy kapitali|SAGE (Sage Therapeutics, Inc) - Kompaniyaning sof aktivlari|Kompaniyaning sof aktivlari Synaptogenix, Inc|TRVN - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati VIGL|Kompaniyaning balans qiymati CERE (Cerevel Therapeutics, Inc.)